24/7 Patient Assistance: 760-405-8205

James R. Berenson, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Asbestosis Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

Hospitals & Clinics

  • Bio & Insurance Information

    Dr. James Berenson is a medical oncologist from West Hollywood, California. He has been working in the medical field for the past 40 years. Dr. Berenson graduated from the University of California San Diego School of Medicine. He completed his residency at University of Utah and the fellowship stage at the University of California at Los Angeles (UCLA). Dr. James Berenson is a board-certified specialist in internal medicine and oncology. He has been actively involved in the research field throughout his career. Some of the topics he focused on in his studies are refractory multiple myelomas, anti-myeloma agents, panobinostat potential for patients with relapsed and refractory multiple myelomas. Dr. Berenson currently works for the Cedars-Sinai Medical Center in Los Angeles.



  • Education & Training

    dept_icon

    University of California San Diego School of Medicine

    Medical School

    dept_icon

    University of Utah

    Residency

    dept_icon

    University of California at Los Angeles (UCLA)

    Fellowship

  • Board Certifications

    American Board of Internal Medicine

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    Cedars-Sinai Medical Center

    Languages: English/Spanish

    (310) 423-3277

    8700 Beverly Blvd

    Los Angeles, California 90048

    Read More
  • Publications & Memberships

    Dr. James R. Berenson has contributed to 3 publications.

    CHAMPION-1: a phase 1/2 study of weekly carfilzomib and dexamethasone for relapsed or relapsed and refractory multiple myeloma.

    Berenson, J. R.,Cartmell, A.,Bessudo, A.,Lyons, R. M.,Harb, W.,Tzachanis, D.,Agajanian, R.,Boccia, R.,Coleman, M.,Moss, R. A.,Rifkin, R. M.,Patel, P.,Dixon, S.,Ou, Y.,...; Blood. 2016 May 22.

    See more >>

    Synthesis and evaluation of 2-alkylthio-4-(N-substituted sulfonamide)pyrimidine hydroxamic acids as anti-myeloma agents.

    Xiang, J.,Leung, C.,Zhang, Z.,Hu, C.,Geng, C.,Liu, L.,Yi, L.,Li, Z.,Berenson, J.,Bai, X.; Chem Biol Drug Des. 2015 Nov 01.

    See more >>

    The potential of panobinostat as a treatment option in patients with relapsed and refractory multiple myeloma.

    Andreu-Vieyra, C. V.,Berenson, J. R.; Ther Adv Hematol. 2014 Dec 04.

    See more >>

    Memberships

    American Society of Clinical Oncology